149 related articles for article (PubMed ID: 15652392)
1. Clonidine pre-treatment fails to block acute smoking-induced EEG arousal/mood in cigarette smokers.
Knott VJ; Raegele M; Fisher D; Robertson N; Millar A; McIntosh J; Ilivitsky V
Pharmacol Biochem Behav; 2005 Jan; 80(1):161-71. PubMed ID: 15652392
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
Knott VJ; Fisher DJ
Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Craving-induced EEG reactivity in smokers: effects of mood induction, nicotine dependence and gender.
Knott VJ; Naccache L; Cyr E; Fisher DJ; McIntosh JF; Millar AM; Villeneuve CM
Neuropsychobiology; 2008; 58(3-4):187-99. PubMed ID: 19212134
[TBL] [Abstract][Full Text] [Related]
5. EEG correlates of imagery-induced cigarette craving in male and female smokers.
Knott V; Cosgrove M; Villeneuve C; Fisher D; Millar A; McIntosh J
Addict Behav; 2008 Apr; 33(4):616-21. PubMed ID: 18077100
[TBL] [Abstract][Full Text] [Related]
6. Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist.
Knott V; McIntosh J; Millar A; Fisher D; Villeneuve C; Ilivitsky V; Horn E
Pharmacol Biochem Behav; 2006 Sep; 85(1):228-42. PubMed ID: 17023037
[TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
Ornish SA; Zisook S; McAdams LA
Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
[TBL] [Abstract][Full Text] [Related]
8. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials.
Knott V; Bosman M; Mahoney C; Ilivitsky V; Quirt K
Pharmacol Biochem Behav; 1999 Jun; 63(2):253-61. PubMed ID: 10371654
[TBL] [Abstract][Full Text] [Related]
9. Changes in the electroencephalographic spectrum in response to smoking cues in smokers and ex-smokers.
Littel M; Franken IH; Van Strien JW
Neuropsychobiology; 2009; 59(1):43-50. PubMed ID: 19270463
[TBL] [Abstract][Full Text] [Related]
10. Effects of tryptophan depletion on acute smoking abstinence symptoms and the acute smoking response.
Perugini M; Mahoney C; Ilivitsky V; Young SN; Knott V
Pharmacol Biochem Behav; 2003 Feb; 74(3):513-22. PubMed ID: 12543214
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute nicotine administration on resting EEG in nonsmokers.
Fisher DJ; Daniels R; Jaworska N; Knobelsdorf A; Knott VJ
Exp Clin Psychopharmacol; 2012 Feb; 20(1):71-5. PubMed ID: 21875223
[TBL] [Abstract][Full Text] [Related]
13. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
[TBL] [Abstract][Full Text] [Related]
14. Acute nicotine fails to alter event-related potential or behavioral performance indices of auditory distraction in cigarette smokers.
Knott VJ; Scherling CS; Blais CM; Camarda J; Fisher DJ; Millar A; McIntosh JF
Nicotine Tob Res; 2006 Apr; 8(2):263-73. PubMed ID: 16766419
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers.
Smith A; Sutherland D; Christopher G
J Psychopharmacol; 2005 Nov; 19(6):620-6. PubMed ID: 16272184
[TBL] [Abstract][Full Text] [Related]
16. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
17. The effect of nicotine and attention allocation on physiological and self-report measures of induced anxiety in PTSD: a double-blind placebo-controlled trial.
Buckley TC; Holohan DR; Mozley SL; Walsh K; Kassel J
Exp Clin Psychopharmacol; 2007 Apr; 15(2):154-64. PubMed ID: 17469939
[TBL] [Abstract][Full Text] [Related]
18. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
Saletu B; Grünberger J; Anderer P; Chwatal K
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
[TBL] [Abstract][Full Text] [Related]
19. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C
J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446
[TBL] [Abstract][Full Text] [Related]
20. Modafinil and nicotine interactions in abstinent smokers.
Sofuoglu M; Waters AJ; Mooney M
Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
